Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Adicionar filtros








Intervalo de ano
1.
Alexandria Journal of Veterinary Sciences [AJVS]. 1990; 6 (1): 259-266
em Inglês | IMEMR | ID: emr-15321

RESUMO

Bacteriological examination of faecal swabs obtained from newlyborn buffaloe calves [7 days to one month of age] suffering from diarrhea, E.coli was isolated from all samples. Serological identification revealed that the isolated strains were grouped into serotypes O[26], O[55], O[78], O[86], O[101], O[111] O[114], O[119], O[124], O[125], O[126], O[127], and O[142]. Calves with higher serum immune globulins concentration survived, while thoset of known low serum immune globulins concentration showed no beneficial effects from using chloramphenicol or furazolidon in the prevention of deaths from E.coli diarrhea


Assuntos
Animais , Infecções por Escherichia coli/tratamento farmacológico , Búfalos , Cloranfenicol , Furazolidona
2.
Alexandria Journal of Veterinary Sciences [AJVS]. 1990; 6 (1): 267-275
em Inglês | IMEMR | ID: emr-15322

RESUMO

Field trials in sheep and lambs were carried out with Cl. welchii type B vaccine used alone or in combination with Cl. welchii type D. Effective responses were obtained and there was no observable interference when antigens were combined nor did passive Beta antitoxine or epsilon antitoxin prevent response to Cl. welchii type B toxoid or Cl. welchii type D toxoid in lambs. Moreover complete passive protection against lamb dysentery and pulpy kidney diseases occurred up to 8 weeks of age in lambs born to ewes inoculated with the routine dose of 2 ml. Cl. welchii type B or Cl. welchii type D before lambing, whether this was a booster dose or the second dose of the primary series. In a small selected group 30% were still protected at 16 weeks of age. Doubling the dose of vaccine significantly raised the titres of ewes at parturition and also increased the percentage of passively protected lambs to 50%


Assuntos
Animais , Clostridium perfringens/imunologia , Vacinação , Imunização Passiva , Antitoxinas
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA